Extraterrestrial genome doctrine

Introduction

The extraterrestrial genome doctrine concerns the hypothetical legal and ethical framework governing the discovery, collection, sequencing, storage, analysis, modification, ownership, and possible commercial use of genetic material originating from extraterrestrial life.

“Extraterrestrial genome doctrine” is not an established doctrine in current Indian or international law. No court has yet adjudicated ownership or legal rights concerning the genome of extraterrestrial organisms. The concept must therefore be developed by applying existing principles of space law, biotechnology regulation, intellectual property, biosafety, environmental law, privacy, and international scientific cooperation.

The central legal question is whether extraterrestrial genetic material should be treated as a scientific resource, biological property, a common scientific heritage, or material subject to special international restrictions.

Meaning and scope

Extraterrestrial genome governance could cover:

• collection of genetic material from extraterrestrial organisms;
• sequencing of extraterrestrial DNA or RNA;
• preservation of extraterrestrial genetic samples;
• publication of genomic information;
• genetic modification of extraterrestrial organisms;
• creation of synthetic sequences based on extraterrestrial genomes;
• commercialisation of extraterrestrial biological discoveries; and
• protection against contamination.

The legal analysis would differ substantially depending on whether the genetic material came from a living organism, fossil material, dormant biological material, or a synthetic reconstruction.

Outer Space Treaty and non-appropriation

The Outer Space Treaty 1967 is the principal starting point.

Article II provides that outer space, including the Moon and other celestial bodies, is not subject to national appropriation by sovereignty, use, occupation, or other means.

This creates an important distinction between extracting a biological sample and claiming sovereignty over the celestial body from which the sample originated.

The Treaty does not expressly answer whether private parties can own extraterrestrial biological material after lawful collection. Consequently, there is currently significant legal uncertainty concerning private ownership of extraterrestrial biological resources.

Extraterrestrial genetic material as a biological resource

A major question would be whether extraterrestrial genetic material should be treated similarly to biological resources on Earth.

The Convention on Biological Diversity (CBD) establishes principles concerning biological diversity and genetic resources on Earth. However, it does not clearly govern extraterrestrial organisms.

The Nagoya Protocol similarly concerns access to genetic resources and benefit-sharing within the CBD framework and does not provide a direct regime for extraterrestrial genomes.

Accordingly, applying terrestrial genetic-resource rules automatically to extraterrestrial organisms would be legally uncertain.

A future space-specific treaty may be necessary.

Scientific discovery and ownership

A distinction should be made between discovering a genome and creating a technological invention based on it.

In Association for Molecular Pathology v. Myriad Genetics, Inc. (2013), the US Supreme Court held that naturally occurring DNA is not patentable merely because it has been isolated.

The principle could be relevant by analogy: merely discovering an extraterrestrial genetic sequence would not necessarily justify exclusive ownership over the naturally occurring sequence.

However, substantial human engineering or synthetic reconstruction could raise a different patent question.

Biotechnology and patent protection

In Diamond v. Chakrabarty (1980), the US Supreme Court held that a genetically engineered microorganism could qualify for patent protection.

This distinction could become relevant if researchers modified an extraterrestrial genetic sequence to create a genuinely novel technological product.

For example, a naturally occurring extraterrestrial gene sequence and a human-engineered biological system incorporating that sequence might receive different legal treatment.

Nevertheless, patentability would remain subject to the applicable national patent statute.

Indian patent law

Indian patent law contains significant limitations on the patentability of biological discoveries.

The Patents Act, 1970, particularly provisions concerning discoveries of living substances occurring in nature, places important restrictions on patents based merely on discovery.

The principles reflected in Novartis AG v. Union of India (2013) also demonstrate India's approach to preventing inappropriate expansion of pharmaceutical patent monopolies while maintaining incentives for genuine innovation.

An extraterrestrial genome would present an entirely novel question, but the distinction between discovery and invention would remain highly relevant.

Biosafety

Extraterrestrial genomes could pose unknown biological risks.

A sequence that appears harmless could potentially encode biological functions that are not understood by terrestrial science.

Consequently, researchers should consider:

• laboratory containment;
• genetic sequencing safeguards;
• controlled storage;
• contamination prevention;
• restricted access;
• risk assessment; and
• emergency procedures.

The Outer Space Treaty Article IX requirement to avoid harmful contamination provides an important foundation for planetary protection.

Forward and backward contamination

Extraterrestrial genome governance involves two related risks.

Forward contamination occurs when Earth organisms are introduced into extraterrestrial environments.

Backward contamination occurs when potentially harmful extraterrestrial organisms or biological material are brought back to Earth.

The COSPAR Planetary Protection Policy provides internationally recognised scientific guidelines addressing these risks.

However, COSPAR policy is not itself a universal treaty and therefore depends substantially on national implementation and mission requirements.

Genetic modification of extraterrestrial organisms

A particularly difficult question would arise if scientists attempted to modify an extraterrestrial organism genetically.

Such experimentation could:

• alter an extraterrestrial ecosystem;
• destroy unique biological characteristics;
• create unknown biological risks;
• affect future scientific study; or
• interfere with an extraterrestrial organism's survival.

The precautionary principle would therefore be highly relevant.

In Vellore Citizens' Welfare Forum v. Union of India (1996), the Supreme Court recognised the precautionary principle as part of Indian environmental law.

Although Vellore concerns terrestrial environmental protection, its reasoning provides an important analogy for potentially irreversible biological interventions.

Genetic information and privacy

If extraterrestrial organisms possessed sophisticated cognition, genome sequencing could potentially raise privacy questions.

For an ordinary microorganism, privacy would likely have little conceptual relevance. But if an extraterrestrial intelligent species possessed genetic information closely connected to individual identity, reproduction, or cognition, unrestricted genomic sequencing could raise substantially different ethical concerns.

The principles of informational autonomy recognised in Puttaswamy (2017) could provide a conceptual foundation, although Indian constitutional privacy currently protects human persons and does not automatically extend to extraterrestrial entities.

Commercial exploitation

Companies might seek to commercialise extraterrestrial genetic discoveries for:

• pharmaceuticals;
• biotechnology;
• synthetic biology;
• materials;
• agriculture; or
• industrial applications.

A future legal regime would need to address benefit sharing, licensing, scientific access, environmental safeguards, and potential monopolisation.

Allowing a single company to obtain permanent control over an extraterrestrial genome could raise international questions concerning the non-appropriation principle.

State responsibility

Private space companies may increasingly conduct missions involving sample collection.

Under the Outer Space Treaty, states remain responsible for national activities in outer space and must authorise and continuously supervise non-governmental activities.

Therefore, governments could have obligations to establish appropriate licensing, biosafety, sample-return, and genomic research requirements.

A state could not necessarily avoid responsibility merely by allowing a private corporation to conduct the mission.

Evidence and authenticity

Extraterrestrial genome claims would require unusually strong scientific verification.

A purported extraterrestrial sequence could result from:

• terrestrial contamination;
• laboratory contamination;
• sequencing error;
• computational artefacts;
• sample misidentification; or
• deliberate fraud.

A proper governance system would therefore require independent replication, chain-of-custody records, validated sequencing methods, and independent scientific review.

Expert evidence could become critical in subsequent legal proceedings.

Under State of Himachal Pradesh v. Jai Lal (1999), the Supreme Court explained that expert opinion is advisory and must be evaluated by the court rather than accepted automatically.

International cooperation

Because extraterrestrial genetic discoveries could have global scientific and security consequences, unilateral control may be problematic.

A future international framework could require:

• notification of major discoveries;
• controlled sample repositories;
• independent verification;
• international scientific access;
• planetary-protection assessment;
• benefit-sharing mechanisms; and
• restrictions on dangerous genetic modification.

The existing space-law framework provides a starting point but does not yet comprehensively regulate these issues.

Case laws

Association for Molecular Pathology v. Myriad Genetics, Inc. (2013) — distinguishes naturally occurring genetic material from patentable human-created genetic inventions.

Diamond v. Chakrabarty (1980) — demonstrates that human-engineered biological organisms can, under certain legal systems, qualify for patent protection.

Novartis AG v. Union of India (2013) — illustrates India's approach to pharmaceutical patents and the balance between innovation and public access.

Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) — establishes principles of informational privacy and autonomy that could become relevant if extraterrestrial genomic information were associated with intelligent entities.

Vellore Citizens' Welfare Forum v. Union of India (1996) — recognises the precautionary principle, relevant to potentially irreversible extraterrestrial biological interventions.

State of Himachal Pradesh v. Jai Lal (1999) — provides principles concerning the evaluation of scientific expert evidence, relevant to authentication of alleged extraterrestrial genomic material.

These are analogical authorities rather than direct extraterrestrial-genome precedents.

Future governance framework

A future extraterrestrial genome regime could establish:

1. mandatory reporting of verified extraterrestrial biological discoveries;
2. strict sample-containment standards;
3. independent scientific authentication;
4. international registration of significant extraterrestrial genomes;
5. restrictions on unilateral appropriation;
6. controlled commercial use;
7. biosafety and planetary-protection assessments;
8. rules concerning synthetic reconstruction;
9. special protection where intelligent life is involved; and
10. international dispute-resolution mechanisms.

The regime should distinguish between scientific access to genetic information and exclusive ownership of biological resources.

Conclusion

The extraterrestrial genome doctrine remains hypothetical and legally undeveloped. Existing international space law does not clearly establish who owns extraterrestrial genetic material or whether naturally occurring extraterrestrial genomes can be commercially appropriated.

The strongest existing principles come from the Outer Space Treaty, planetary-protection standards, patent law, precautionary environmental jurisprudence, and biotechnology governance.

Cases such as Myriad Genetics, Chakrabarty, Novartis, Puttaswamy, and Vellore provide useful analogies concerning genetic information, biotechnology inventions, privacy, and precaution.

Ultimately, extraterrestrial genomes should probably be governed through a framework that promotes scientific research while preventing unilateral appropriation, uncontrolled genetic manipulation, biological contamination, and irreversible harm. If extraterrestrial intelligent life were involved, the framework would also need to incorporate autonomy, dignity, cognitive rights, and protection against exploitation.